Global Anti-Venom Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Anti-Venom
- 1.1 Definition of Anti-Venom
- 1.2 Anti-Venom Segment by Type
- 1.2.1 Global Anti-Venom Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Cytotoxic
- 1.2.3 Neurotoxic
- 1.2.4 Haemotoxic
- 1.2.5 Cardiotoxic
- 1.2.6 Myotoxic
- 1.3 Anti-Venom Segment by Applications
- 1.3.1 Global Anti-Venom Consumption Comparison by Applications (2014-2025)
- 1.3.2 Snake
- 1.3.3 Spider
- 1.3.4 Scorpion
- 1.4 Global Anti-Venom Overall Market
- 1.4.1 Global Anti-Venom Revenue (2014-2025)
- 1.4.2 Global Anti-Venom Production (2014-2025)
- 1.4.3 North America Anti-Venom Status and Prospect (2014-2025)
- 1.4.4 Europe Anti-Venom Status and Prospect (2014-2025)
- 1.4.5 China Anti-Venom Status and Prospect (2014-2025)
- 1.4.6 Japan Anti-Venom Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Anti-Venom Status and Prospect (2014-2025)
- 1.4.8 India Anti-Venom Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Anti-Venom
- 2.3 Manufacturing Process Analysis of Anti-Venom
- 2.4 Industry Chain Structure of Anti-Venom
3 Development and Manufacturing Plants Analysis of Anti-Venom
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Anti-Venom Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Anti-Venom
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Anti-Venom Production and Capacity Analysis
- 4.2 Anti-Venom Revenue Analysis
- 4.3 Anti-Venom Price Analysis
- 4.4 Market Concentration Degree
5 Anti-Venom Regional Market Analysis
- 5.1 Anti-Venom Production by Regions
- 5.1.1 Global Anti-Venom Production by Regions
- 5.1.2 Global Anti-Venom Revenue by Regions
- 5.2 Anti-Venom Consumption by Regions
- 5.3 North America Anti-Venom Market Analysis
- 5.3.1 North America Anti-Venom Production
- 5.3.2 North America Anti-Venom Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Anti-Venom Import and Export
- 5.4 Europe Anti-Venom Market Analysis
- 5.4.1 Europe Anti-Venom Production
- 5.4.2 Europe Anti-Venom Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Anti-Venom Import and Export
- 5.5 China Anti-Venom Market Analysis
- 5.5.1 China Anti-Venom Production
- 5.5.2 China Anti-Venom Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Anti-Venom Import and Export
- 5.6 Japan Anti-Venom Market Analysis
- 5.6.1 Japan Anti-Venom Production
- 5.6.2 Japan Anti-Venom Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Anti-Venom Import and Export
- 5.7 Southeast Asia Anti-Venom Market Analysis
- 5.7.1 Southeast Asia Anti-Venom Production
- 5.7.2 Southeast Asia Anti-Venom Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Anti-Venom Import and Export
- 5.8 India Anti-Venom Market Analysis
- 5.8.1 India Anti-Venom Production
- 5.8.2 India Anti-Venom Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Anti-Venom Import and Export
6 Anti-Venom Segment Market Analysis (by Type)
- 6.1 Global Anti-Venom Production by Type
- 6.2 Global Anti-Venom Revenue by Type
- 6.3 Anti-Venom Price by Type
7 Anti-Venom Segment Market Analysis (by Application)
- 7.1 Global Anti-Venom Consumption by Application
- 7.2 Global Anti-Venom Consumption Market Share by Application (2014-2019)
8 Anti-Venom Major Manufacturers Analysis
- 8.1 Medtoxin Venom Laboratories
- 8.1.1 Medtoxin Venom Laboratories Anti-Venom Production Sites and Area Served
- 8.1.2 Medtoxin Venom Laboratories Product Introduction, Application and Specification
- 8.1.3 Medtoxin Venom Laboratories Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Institute of Immunology
- 8.2.1 Institute of Immunology Anti-Venom Production Sites and Area Served
- 8.2.2 Institute of Immunology Product Introduction, Application and Specification
- 8.2.3 Institute of Immunology Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Alomone Labs
- 8.3.1 Alomone Labs Anti-Venom Production Sites and Area Served
- 8.3.2 Alomone Labs Product Introduction, Application and Specification
- 8.3.3 Alomone Labs Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Sigma Aldrich
- 8.4.1 Sigma Aldrich Anti-Venom Production Sites and Area Served
- 8.4.2 Sigma Aldrich Product Introduction, Application and Specification
- 8.4.3 Sigma Aldrich Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Wyeth Pharmaceuticals
- 8.5.1 Wyeth Pharmaceuticals Anti-Venom Production Sites and Area Served
- 8.5.2 Wyeth Pharmaceuticals Product Introduction, Application and Specification
- 8.5.3 Wyeth Pharmaceuticals Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Protherics PLC
- 8.6.1 Protherics PLC Anti-Venom Production Sites and Area Served
- 8.6.2 Protherics PLC Product Introduction, Application and Specification
- 8.6.3 Protherics PLC Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Bharat Serums and Vaccines
- 8.7.1 Bharat Serums and Vaccines Anti-Venom Production Sites and Area Served
- 8.7.2 Bharat Serums and Vaccines Product Introduction, Application and Specification
- 8.7.3 Bharat Serums and Vaccines Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Butantan Institute
- 8.8.1 Butantan Institute Anti-Venom Production Sites and Area Served
- 8.8.2 Butantan Institute Product Introduction, Application and Specification
- 8.8.3 Butantan Institute Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Haffkine Bio-Pharmaceutical Corporation
- 8.9.1 Haffkine Bio-Pharmaceutical Corporation Anti-Venom Production Sites and Area Served
- 8.9.2 Haffkine Bio-Pharmaceutical Corporation Product Introduction, Application and Specification
- 8.9.3 Haffkine Bio-Pharmaceutical Corporation Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Micropaharm Limited
- 8.10.1 Micropaharm Limited Anti-Venom Production Sites and Area Served
- 8.10.2 Micropaharm Limited Product Introduction, Application and Specification
- 8.10.3 Micropaharm Limited Anti-Venom Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Anti-Venom Market
- 9.1 Global Anti-Venom Market Trend Analysis
- 9.1.1 Global Anti-Venom Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Anti-Venom Regional Market Trend
- 9.2.1 North America Anti-Venom Forecast 2019-2025
- 9.2.2 Europe Anti-Venom Forecast 2019-2025
- 9.2.3 China Anti-Venom Forecast 2019-2025
- 9.2.4 Japan Anti-Venom Forecast 2019-2025
- 9.2.5 Southeast Asia Anti-Venom Forecast 2019-2025
- 9.2.6 India Anti-Venom Forecast 2019-2025
- 9.3 Anti-Venom Market Trend (Product Type)
- 9.4 Anti-Venom Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Anti-Venom Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
The global Anti-Venom market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Venom volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Venom market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Venom in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Anti-Venom manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medtoxin Venom Laboratories
Institute of Immunology
Alomone Labs
Sigma Aldrich
Wyeth Pharmaceuticals
Protherics PLC
Bharat Serums and Vaccines
Butantan Institute
Haffkine Bio-Pharmaceutical Corporation
Micropaharm Limited
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Cytotoxic
Neurotoxic
Haemotoxic
Cardiotoxic
Myotoxic
Segment by Application
Snake
Spider
Scorpion